Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man.
about
Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case reportInfliximab treatment reduces complement activation in patients with rheumatoid arthritis.Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case reportThe sensitivity and specificity of Lassa virus IgM by ELISA as screening tool at early phase of Lassa fever infectionUnexpected hematologic effects of biotherapeutics in nonclinical species and in humans.
P2860
Thrombocytopenia and complement activation under recombinant TNF alpha/IFN gamma therapy in man.
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@ast
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@en
type
label
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@ast
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@en
prefLabel
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@ast
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@en
P2093
P356
P1433
P1476
Thrombocytopenia and complemen ...... lpha/IFN gamma therapy in man.
@en
P2093
Böckmann D
Eckhof-Donovan S
Michelmann I
Nürnberger W
P304
P356
10.1007/S002770050279
P577
1997-04-01T00:00:00Z